MODULATION OF GENE EXPRESSION ASSOCIATED WITH INFLAMMATION PROLIFERATION AND NEURITE OUTGROWTH, USING NUCLEIC ACID BASED TECHNOLOGIES

Details for Australian Patent Application No. 2002307099 (hide)

Owner RIBOZYME PHARMACEUTICALS, INCORPORATED

Inventors BLATT, Lawrence; CHOWRIRA, Bharat; HAEBERLI, Peter; MCSWIGGEN, James; FOSNAUGH, Kathy

Pub. Number AU-A-2002307099

PCT Number PCT/US02/10512

PCT Pub. Number WO2002/081628

Priority 09/827,395 05.04.01 US; 60/294,412 29.05.01 US; 60/315,315 28.08.01 US

Filing date 3 April 2002

Wipo publication date 21 October 2002

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/827,395 05.04.01 US; 60/294,412 29.05.01 US; 60/315,315 28.08.01 US

10 April 2003 Application Open to Public Inspection

  Published as AU-A-2002307099

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307100-USE OF TUMOR NECROSIS FACTOR INHIBITORS TO TREAT CARDIOVASCULAR DISEASE

2002307098-METHOD OF IMAGING CELL DEATH IN VIVO